cellometer Search Results


ivis system  (Revvity)
96
Revvity ivis system
(a) Experimental scheme for in vivo screening. C57BL/6N mice were intramuscularly administered fLuc mRNA-loaded LNPs (0.05 mg/kg) and bioluminescence was assessed at 6 h post-injection by <t>IVIS</t> imaging. (b) Representative in vivo IVIS bioluminescence images of nine LNP formulations. (c) Quantification of bioluminescence signals at the injection site. (d) Quantification of bioluminescence signals in the liver. (e) Injection site-to-liver bioluminescence ratio (n = 2 per group). N4Y and N4Z were selected as lead candidates based on high injection site expression and minimal hepatic off-target signal. (f, g) Time-dependent serum levels of MCP-1 (f) and IL-6 (g) following intramuscular administration of N4Y- or N4Z-based LNPs encapsulating SARS-CoV-2 spike mRNA (0.5 mg/kg) in BALB/c mice (n = 4 per group). Statistical significance was determined by unpaired two-tailed Student’s t-test at each time point. Data are presented as mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001.
Ivis System, supplied by Revvity, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ivis system/product/Revvity
Average 96 stars, based on 1 article reviews
ivis system - by Bioz Stars, 2026-05
96/100 stars
  Buy from Supplier
victor nivo multimode plate reader  (Revvity)
96
Revvity victor nivo multimode plate reader
(a) Experimental scheme for in vivo screening. C57BL/6N mice were intramuscularly administered fLuc mRNA-loaded LNPs (0.05 mg/kg) and bioluminescence was assessed at 6 h post-injection by <t>IVIS</t> imaging. (b) Representative in vivo IVIS bioluminescence images of nine LNP formulations. (c) Quantification of bioluminescence signals at the injection site. (d) Quantification of bioluminescence signals in the liver. (e) Injection site-to-liver bioluminescence ratio (n = 2 per group). N4Y and N4Z were selected as lead candidates based on high injection site expression and minimal hepatic off-target signal. (f, g) Time-dependent serum levels of MCP-1 (f) and IL-6 (g) following intramuscular administration of N4Y- or N4Z-based LNPs encapsulating SARS-CoV-2 spike mRNA (0.5 mg/kg) in BALB/c mice (n = 4 per group). Statistical significance was determined by unpaired two-tailed Student’s t-test at each time point. Data are presented as mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001.
Victor Nivo Multimode Plate Reader, supplied by Revvity, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/victor nivo multimode plate reader/product/Revvity
Average 96 stars, based on 1 article reviews
victor nivo multimode plate reader - by Bioz Stars, 2026-05
96/100 stars
  Buy from Supplier
opera phenix  (Revvity)
96
Revvity opera phenix
(a) Experimental scheme for in vivo screening. C57BL/6N mice were intramuscularly administered fLuc mRNA-loaded LNPs (0.05 mg/kg) and bioluminescence was assessed at 6 h post-injection by <t>IVIS</t> imaging. (b) Representative in vivo IVIS bioluminescence images of nine LNP formulations. (c) Quantification of bioluminescence signals at the injection site. (d) Quantification of bioluminescence signals in the liver. (e) Injection site-to-liver bioluminescence ratio (n = 2 per group). N4Y and N4Z were selected as lead candidates based on high injection site expression and minimal hepatic off-target signal. (f, g) Time-dependent serum levels of MCP-1 (f) and IL-6 (g) following intramuscular administration of N4Y- or N4Z-based LNPs encapsulating SARS-CoV-2 spike mRNA (0.5 mg/kg) in BALB/c mice (n = 4 per group). Statistical significance was determined by unpaired two-tailed Student’s t-test at each time point. Data are presented as mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001.
Opera Phenix, supplied by Revvity, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/opera phenix/product/Revvity
Average 96 stars, based on 1 article reviews
opera phenix - by Bioz Stars, 2026-05
96/100 stars
  Buy from Supplier
cellometer auto t4 plus  (Revvity)
96
Revvity cellometer auto t4 plus
(a) Experimental scheme for in vivo screening. C57BL/6N mice were intramuscularly administered fLuc mRNA-loaded LNPs (0.05 mg/kg) and bioluminescence was assessed at 6 h post-injection by <t>IVIS</t> imaging. (b) Representative in vivo IVIS bioluminescence images of nine LNP formulations. (c) Quantification of bioluminescence signals at the injection site. (d) Quantification of bioluminescence signals in the liver. (e) Injection site-to-liver bioluminescence ratio (n = 2 per group). N4Y and N4Z were selected as lead candidates based on high injection site expression and minimal hepatic off-target signal. (f, g) Time-dependent serum levels of MCP-1 (f) and IL-6 (g) following intramuscular administration of N4Y- or N4Z-based LNPs encapsulating SARS-CoV-2 spike mRNA (0.5 mg/kg) in BALB/c mice (n = 4 per group). Statistical significance was determined by unpaired two-tailed Student’s t-test at each time point. Data are presented as mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001.
Cellometer Auto T4 Plus, supplied by Revvity, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cellometer auto t4 plus/product/Revvity
Average 96 stars, based on 1 article reviews
cellometer auto t4 plus - by Bioz Stars, 2026-05
96/100 stars
  Buy from Supplier
cellometertm mini automated cell counter  (Revvity)
96
Revvity cellometertm mini automated cell counter
(a) Experimental scheme for in vivo screening. C57BL/6N mice were intramuscularly administered fLuc mRNA-loaded LNPs (0.05 mg/kg) and bioluminescence was assessed at 6 h post-injection by <t>IVIS</t> imaging. (b) Representative in vivo IVIS bioluminescence images of nine LNP formulations. (c) Quantification of bioluminescence signals at the injection site. (d) Quantification of bioluminescence signals in the liver. (e) Injection site-to-liver bioluminescence ratio (n = 2 per group). N4Y and N4Z were selected as lead candidates based on high injection site expression and minimal hepatic off-target signal. (f, g) Time-dependent serum levels of MCP-1 (f) and IL-6 (g) following intramuscular administration of N4Y- or N4Z-based LNPs encapsulating SARS-CoV-2 spike mRNA (0.5 mg/kg) in BALB/c mice (n = 4 per group). Statistical significance was determined by unpaired two-tailed Student’s t-test at each time point. Data are presented as mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001.
Cellometertm Mini Automated Cell Counter, supplied by Revvity, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cellometertm mini automated cell counter/product/Revvity
Average 96 stars, based on 1 article reviews
cellometertm mini automated cell counter - by Bioz Stars, 2026-05
96/100 stars
  Buy from Supplier
cellometer k2 fluorescent cell counter  (Revvity)
96
Revvity cellometer k2 fluorescent cell counter
(a) Experimental scheme for in vivo screening. C57BL/6N mice were intramuscularly administered fLuc mRNA-loaded LNPs (0.05 mg/kg) and bioluminescence was assessed at 6 h post-injection by <t>IVIS</t> imaging. (b) Representative in vivo IVIS bioluminescence images of nine LNP formulations. (c) Quantification of bioluminescence signals at the injection site. (d) Quantification of bioluminescence signals in the liver. (e) Injection site-to-liver bioluminescence ratio (n = 2 per group). N4Y and N4Z were selected as lead candidates based on high injection site expression and minimal hepatic off-target signal. (f, g) Time-dependent serum levels of MCP-1 (f) and IL-6 (g) following intramuscular administration of N4Y- or N4Z-based LNPs encapsulating SARS-CoV-2 spike mRNA (0.5 mg/kg) in BALB/c mice (n = 4 per group). Statistical significance was determined by unpaired two-tailed Student’s t-test at each time point. Data are presented as mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001.
Cellometer K2 Fluorescent Cell Counter, supplied by Revvity, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cellometer k2 fluorescent cell counter/product/Revvity
Average 96 stars, based on 1 article reviews
cellometer k2 fluorescent cell counter - by Bioz Stars, 2026-05
96/100 stars
  Buy from Supplier
cellometer k2 image cytometer  (Revvity)
96
Revvity cellometer k2 image cytometer
(a) Experimental scheme for in vivo screening. C57BL/6N mice were intramuscularly administered fLuc mRNA-loaded LNPs (0.05 mg/kg) and bioluminescence was assessed at 6 h post-injection by <t>IVIS</t> imaging. (b) Representative in vivo IVIS bioluminescence images of nine LNP formulations. (c) Quantification of bioluminescence signals at the injection site. (d) Quantification of bioluminescence signals in the liver. (e) Injection site-to-liver bioluminescence ratio (n = 2 per group). N4Y and N4Z were selected as lead candidates based on high injection site expression and minimal hepatic off-target signal. (f, g) Time-dependent serum levels of MCP-1 (f) and IL-6 (g) following intramuscular administration of N4Y- or N4Z-based LNPs encapsulating SARS-CoV-2 spike mRNA (0.5 mg/kg) in BALB/c mice (n = 4 per group). Statistical significance was determined by unpaired two-tailed Student’s t-test at each time point. Data are presented as mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001.
Cellometer K2 Image Cytometer, supplied by Revvity, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cellometer k2 image cytometer/product/Revvity
Average 96 stars, based on 1 article reviews
cellometer k2 image cytometer - by Bioz Stars, 2026-05
96/100 stars
  Buy from Supplier
th115 pcr5h  (Revvity)
94
Revvity th115 pcr5h
(a) Experimental scheme for in vivo screening. C57BL/6N mice were intramuscularly administered fLuc mRNA-loaded LNPs (0.05 mg/kg) and bioluminescence was assessed at 6 h post-injection by <t>IVIS</t> imaging. (b) Representative in vivo IVIS bioluminescence images of nine LNP formulations. (c) Quantification of bioluminescence signals at the injection site. (d) Quantification of bioluminescence signals in the liver. (e) Injection site-to-liver bioluminescence ratio (n = 2 per group). N4Y and N4Z were selected as lead candidates based on high injection site expression and minimal hepatic off-target signal. (f, g) Time-dependent serum levels of MCP-1 (f) and IL-6 (g) following intramuscular administration of N4Y- or N4Z-based LNPs encapsulating SARS-CoV-2 spike mRNA (0.5 mg/kg) in BALB/c mice (n = 4 per group). Statistical significance was determined by unpaired two-tailed Student’s t-test at each time point. Data are presented as mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001.
Th115 Pcr5h, supplied by Revvity, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/th115 pcr5h/product/Revvity
Average 94 stars, based on 1 article reviews
th115 pcr5h - by Bioz Stars, 2026-05
94/100 stars
  Buy from Supplier
1211 rackbeta liquid scintillation counter  (Revvity)
94
Revvity 1211 rackbeta liquid scintillation counter
(a) Experimental scheme for in vivo screening. C57BL/6N mice were intramuscularly administered fLuc mRNA-loaded LNPs (0.05 mg/kg) and bioluminescence was assessed at 6 h post-injection by <t>IVIS</t> imaging. (b) Representative in vivo IVIS bioluminescence images of nine LNP formulations. (c) Quantification of bioluminescence signals at the injection site. (d) Quantification of bioluminescence signals in the liver. (e) Injection site-to-liver bioluminescence ratio (n = 2 per group). N4Y and N4Z were selected as lead candidates based on high injection site expression and minimal hepatic off-target signal. (f, g) Time-dependent serum levels of MCP-1 (f) and IL-6 (g) following intramuscular administration of N4Y- or N4Z-based LNPs encapsulating SARS-CoV-2 spike mRNA (0.5 mg/kg) in BALB/c mice (n = 4 per group). Statistical significance was determined by unpaired two-tailed Student’s t-test at each time point. Data are presented as mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001.
1211 Rackbeta Liquid Scintillation Counter, supplied by Revvity, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/1211 rackbeta liquid scintillation counter/product/Revvity
Average 94 stars, based on 1 article reviews
1211 rackbeta liquid scintillation counter - by Bioz Stars, 2026-05
94/100 stars
  Buy from Supplier
cell viability  (Revvity)
96
Revvity cell viability
(a) Experimental scheme for in vivo screening. C57BL/6N mice were intramuscularly administered fLuc mRNA-loaded LNPs (0.05 mg/kg) and bioluminescence was assessed at 6 h post-injection by <t>IVIS</t> imaging. (b) Representative in vivo IVIS bioluminescence images of nine LNP formulations. (c) Quantification of bioluminescence signals at the injection site. (d) Quantification of bioluminescence signals in the liver. (e) Injection site-to-liver bioluminescence ratio (n = 2 per group). N4Y and N4Z were selected as lead candidates based on high injection site expression and minimal hepatic off-target signal. (f, g) Time-dependent serum levels of MCP-1 (f) and IL-6 (g) following intramuscular administration of N4Y- or N4Z-based LNPs encapsulating SARS-CoV-2 spike mRNA (0.5 mg/kg) in BALB/c mice (n = 4 per group). Statistical significance was determined by unpaired two-tailed Student’s t-test at each time point. Data are presented as mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001.
Cell Viability, supplied by Revvity, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cell viability/product/Revvity
Average 96 stars, based on 1 article reviews
cell viability - by Bioz Stars, 2026-05
96/100 stars
  Buy from Supplier
spectrometer  (Revvity)
96
Revvity spectrometer
(a) Experimental scheme for in vivo screening. C57BL/6N mice were intramuscularly administered fLuc mRNA-loaded LNPs (0.05 mg/kg) and bioluminescence was assessed at 6 h post-injection by <t>IVIS</t> imaging. (b) Representative in vivo IVIS bioluminescence images of nine LNP formulations. (c) Quantification of bioluminescence signals at the injection site. (d) Quantification of bioluminescence signals in the liver. (e) Injection site-to-liver bioluminescence ratio (n = 2 per group). N4Y and N4Z were selected as lead candidates based on high injection site expression and minimal hepatic off-target signal. (f, g) Time-dependent serum levels of MCP-1 (f) and IL-6 (g) following intramuscular administration of N4Y- or N4Z-based LNPs encapsulating SARS-CoV-2 spike mRNA (0.5 mg/kg) in BALB/c mice (n = 4 per group). Statistical significance was determined by unpaired two-tailed Student’s t-test at each time point. Data are presented as mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001.
Spectrometer, supplied by Revvity, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/spectrometer/product/Revvity
Average 96 stars, based on 1 article reviews
spectrometer - by Bioz Stars, 2026-05
96/100 stars
  Buy from Supplier
phenovue cell painting kit  (Revvity)
94
Revvity phenovue cell painting kit
(a) Experimental scheme for in vivo screening. C57BL/6N mice were intramuscularly administered fLuc mRNA-loaded LNPs (0.05 mg/kg) and bioluminescence was assessed at 6 h post-injection by <t>IVIS</t> imaging. (b) Representative in vivo IVIS bioluminescence images of nine LNP formulations. (c) Quantification of bioluminescence signals at the injection site. (d) Quantification of bioluminescence signals in the liver. (e) Injection site-to-liver bioluminescence ratio (n = 2 per group). N4Y and N4Z were selected as lead candidates based on high injection site expression and minimal hepatic off-target signal. (f, g) Time-dependent serum levels of MCP-1 (f) and IL-6 (g) following intramuscular administration of N4Y- or N4Z-based LNPs encapsulating SARS-CoV-2 spike mRNA (0.5 mg/kg) in BALB/c mice (n = 4 per group). Statistical significance was determined by unpaired two-tailed Student’s t-test at each time point. Data are presented as mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001.
Phenovue Cell Painting Kit, supplied by Revvity, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/phenovue cell painting kit/product/Revvity
Average 94 stars, based on 1 article reviews
phenovue cell painting kit - by Bioz Stars, 2026-05
94/100 stars
  Buy from Supplier

Image Search Results


(a) Experimental scheme for in vivo screening. C57BL/6N mice were intramuscularly administered fLuc mRNA-loaded LNPs (0.05 mg/kg) and bioluminescence was assessed at 6 h post-injection by IVIS imaging. (b) Representative in vivo IVIS bioluminescence images of nine LNP formulations. (c) Quantification of bioluminescence signals at the injection site. (d) Quantification of bioluminescence signals in the liver. (e) Injection site-to-liver bioluminescence ratio (n = 2 per group). N4Y and N4Z were selected as lead candidates based on high injection site expression and minimal hepatic off-target signal. (f, g) Time-dependent serum levels of MCP-1 (f) and IL-6 (g) following intramuscular administration of N4Y- or N4Z-based LNPs encapsulating SARS-CoV-2 spike mRNA (0.5 mg/kg) in BALB/c mice (n = 4 per group). Statistical significance was determined by unpaired two-tailed Student’s t-test at each time point. Data are presented as mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001.

Journal: bioRxiv

Article Title: Coordinated Tuning of Ionizable Lipids and Formulation Redirects mRNA Vaccines Toward Lymphoid-Specific CD4 + T Cell Immunity

doi: 10.64898/2026.04.16.719092

Figure Lengend Snippet: (a) Experimental scheme for in vivo screening. C57BL/6N mice were intramuscularly administered fLuc mRNA-loaded LNPs (0.05 mg/kg) and bioluminescence was assessed at 6 h post-injection by IVIS imaging. (b) Representative in vivo IVIS bioluminescence images of nine LNP formulations. (c) Quantification of bioluminescence signals at the injection site. (d) Quantification of bioluminescence signals in the liver. (e) Injection site-to-liver bioluminescence ratio (n = 2 per group). N4Y and N4Z were selected as lead candidates based on high injection site expression and minimal hepatic off-target signal. (f, g) Time-dependent serum levels of MCP-1 (f) and IL-6 (g) following intramuscular administration of N4Y- or N4Z-based LNPs encapsulating SARS-CoV-2 spike mRNA (0.5 mg/kg) in BALB/c mice (n = 4 per group). Statistical significance was determined by unpaired two-tailed Student’s t-test at each time point. Data are presented as mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001.

Article Snippet: Luciferase expression was assessed by whole-body bioluminescence imaging and ex vivo imaging of harvested organs using an IVIS system (PerkinElmer).

Techniques: In Vivo, Injection, Imaging, Expressing, Two Tailed Test

(a) Schematic comparison of lipid compositions of N4Z and optimized N4Z (N4Z-opt) formulations. (b) mRNA encapsulation efficiency (n = 3). (c) Hydrodynamic diameter (n = 3). (d) Polydispersity index (PDI) (n = 3). (e) Representative flow cytometry contour plots showing GFP expression in RAW 264.7 macrophages following delivery of PBS, N4Z, and N4Z-opt. (f) Mean fluorescence intensity (MFI) of GFP expression in RAW 264.7 macrophages (n = 3). (g) Representative in vivo IVIS bioluminescence images following intramuscular administration of fLuc mRNA-loaded N4Z or N4Z-opt LNPs. (h) Injection site-to-body bioluminescence ratio (n = 3). (i) Representative ex vivo organ images showing bioluminescence in liver, spleen, and lymph node. (j) Spleen-to-liver bioluminescence ratio (n = 3). (k) Lymph node-to-liver bioluminescence ratio (n = 3). Statistical significance for (b–d) was determined by unpaired two-tailed Student’s t -test. Statistical significance for (f, h, j, k) was determined by one-way ANOVA followed by Tukey’s multiple comparisons test. Data are presented as mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001.

Journal: bioRxiv

Article Title: Coordinated Tuning of Ionizable Lipids and Formulation Redirects mRNA Vaccines Toward Lymphoid-Specific CD4 + T Cell Immunity

doi: 10.64898/2026.04.16.719092

Figure Lengend Snippet: (a) Schematic comparison of lipid compositions of N4Z and optimized N4Z (N4Z-opt) formulations. (b) mRNA encapsulation efficiency (n = 3). (c) Hydrodynamic diameter (n = 3). (d) Polydispersity index (PDI) (n = 3). (e) Representative flow cytometry contour plots showing GFP expression in RAW 264.7 macrophages following delivery of PBS, N4Z, and N4Z-opt. (f) Mean fluorescence intensity (MFI) of GFP expression in RAW 264.7 macrophages (n = 3). (g) Representative in vivo IVIS bioluminescence images following intramuscular administration of fLuc mRNA-loaded N4Z or N4Z-opt LNPs. (h) Injection site-to-body bioluminescence ratio (n = 3). (i) Representative ex vivo organ images showing bioluminescence in liver, spleen, and lymph node. (j) Spleen-to-liver bioluminescence ratio (n = 3). (k) Lymph node-to-liver bioluminescence ratio (n = 3). Statistical significance for (b–d) was determined by unpaired two-tailed Student’s t -test. Statistical significance for (f, h, j, k) was determined by one-way ANOVA followed by Tukey’s multiple comparisons test. Data are presented as mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001.

Article Snippet: Luciferase expression was assessed by whole-body bioluminescence imaging and ex vivo imaging of harvested organs using an IVIS system (PerkinElmer).

Techniques: Comparison, Encapsulation, Flow Cytometry, Expressing, Fluorescence, In Vivo, Injection, Ex Vivo, Two Tailed Test